Lynne Ozgur

Discovery of 2-Hydroxy-<i>N</i>,<i>N</i>-dimethyl-3-{2-[[(<i>R</i>)-1-(5- methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobut-1-enylamino}benzamide (SCH 527123):  A Potent, Orally Bioavailable CXCR2/CXCR1 Receptor Antagonist

Michael P. Dwyer, Younong Yu, Jianping Chao et al. · Journal of Medicinal Chemistry · 2006 · 113 citations · Full text

Pharmaceutical Science, Drug Target, Immunology +18

Cloning of a phospholipase A2-activating protein.

M A Clark, Lynne Ozgur, Theresa Conway et al. · Proceedings of the National Academy of Sciences · 1991 · 107 citations · Full text

Proteinlipid Interaction, Immunology, Phospholipase A2 +19

Rational design of novel, potent piperazinone and imidazolidinone BACE1 inhibitors

Jared N. Cumming, Thuy X. Le, Sethu Geetha Babu et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 58 citations · Full text

Medicinal Chemistry, Biochemistry, Drug Design +11

Piperazine sulfonamide BACE1 inhibitors: Design, synthesis, and in vivo characterization

Jared N. Cumming, Suresh Babu, Ying Huang et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 46 citations · Full text

Medicinal Chemistry, Vivo Characterization, Biochemistry +12

Synthesis and structure–activity relationships of 3,4-diaminocyclobut-3-ene-1,2-dione CXCR2 antagonists

J. Robert Merritt, Laura L. Rokosz, Kingsley H. Nelson et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 46 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Medicine +4